Healthcare Industry News: joint replacement
News Release - February 13, 2006
Collagen Matrix Signs Distribution Agreement with Stryker for Distribution of DuraMatrix(TM) Collagen Dura Substitute MembraneFRANKLIN LAKES, N.J., Feb. 13 (HSMN NewsFeed) -- Collagen Matrix, Inc. announced today that it has signed an agreement with Stryker Corporation for the exclusive worldwide distribution of its DuraMatrix(TM) Collagen Dura Substitute Membrane. Since January of 2005, DuraMatrix has been marketed by Collagen Matrix and sold through a network of independent agents and distributors in the U.S. and Europe. Effective immediately, Collagen Matrix will begin transitioning the distribution of DuraMatrix to the Stryker Craniomaxillofacial sales and marketing team. In order to maintain consistency and provide for a smooth transition for our customers, the product will continue to carry the DuraMatrix trade name owned by Collagen Matrix.
DuraMatrix is a safe, resorbable, conformable, collagen-based membrane intended for use as a dura substitute in the repair of dura mater. The unique conformability of the membrane combined with its mechanical strength allows the membrane matrix to be implanted with or without sutures ("onlay"). Animal and clinical studies have shown that the DuraMatrix resorbs slowly over time to allow for host tissue regeneration.
"We are very excited about collaborating with a world-class company such as Stryker for the sales, marketing and distribution of DuraMatrix. The excellent design and performance of the product combined with Stryker's expertise in sales and marketing should dramatically increase DuraMatrix's presence in the field," said Shu-Tung Li, Ph.D., President and CEO of Collagen Matrix.
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. Stryker also provides outpatient physical therapy services in the United States. The Company's website address is http://www.stryker.com
Collagen Matrix, Inc. is a leader in the design and engineer of collagen-based extracellular matrices for tissue and organ repair and regeneration. Since its inception in 1997, the Company has received many government grants for the development of collagen-based matrix products in the areas of neurological, vascular, urological, and orthopedic tissue regeneration applications. The Company currently manufactures collagen-based finished medical devices in the areas of neurosurgery, oral surgery, orthopedic-spine surgery, and wound care. More information about the Company can be found at http://www.collagenmatrix.com.
Source: Collagen Matrix
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.